Nedermaas Hightech Ventures

Total investments

8

Average round size

5M

Portfolio companies

7

Lead investments

1

Follow on index

0.12

Exits

2

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyHealth CareGeneticsMedicalLife SciencePharmaceuticalTherapeuticsEnergy EfficiencyAgricultureDietary Supplements

Summary

The venture was found in Europe in The Netherlands. The main office of represented VC is situated in the Maastricht.

We can highlight the next thriving fund investment areas, such as Life Science, Chemical. Among the various public portfolio startups of the fund, we may underline BioActor, Phenospex, Ekompany Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. The fund has specific favorite in a number of founders of portfolio startups.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Nedermaas Hightech Ventures, startups are often financed by Thuja Capital, EASME - EU Executive Agency for SMEs, Disruptive Capital Finance. The meaningful sponsors for the fund in investment in the same round are Limburg Ventures, NV Industriebank LIOF, Chemelot Ventures. In the next rounds fund is usually obtained by NV Industriebank LIOF, Horizon 2020, Future Food Fund.

The top activity for fund was in 2011. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Nedermaas Hightech Ventures performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2016.

Show more

Investments analytics

Analytics

Total investments
8
Lead investments
1
Exits
2
Follow on index
0.12
Investments by industry
  • Biotechnology (6)
  • Life Science (4)
  • Therapeutics (3)
  • Genetics (2)
  • Pharmaceutical (2)
  • Show 7 more
Investments by region
  • Netherlands (6)
  • United Kingdom (1)
  • France (1)
Peak activity year
2011

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Group Appearance index
1.00
Avg. company exit year
8

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Q Chip 20 May 2011 Biotechnology, Life Science, Therapeutics Late Stage Venture 6M United Kingdom, Wales, Cardiff

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.